Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 19, 2020
Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids
Pankajini Mallick, Gina Song, Alina Y Efremenko, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 21, 2015
Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
Gina Song, Teresa K Tarrant, Taylor F White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models
Gina Song, David B Darr, Charlene M Santos, et al.
Cancer Chemotherapy and Pharmacology
|
January 30, 2016
Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer
Hugh Giovinazzo, Parag Kumar, Arif Sheikh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2025
Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18
Graham L Cohen, Corlia Coetzee, Cathryn A Walton, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 19, 2020
Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids
Pankajini Mallick, Gina Song, Alina Y Efremenko, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 21, 2015
Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
Gina Song, Teresa K Tarrant, Taylor F White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models
Gina Song, David B Darr, Charlene M Santos, et al.
Cancer Chemotherapy and Pharmacology
|
January 30, 2016
Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer
Hugh Giovinazzo, Parag Kumar, Arif Sheikh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2025
Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18
Graham L Cohen, Corlia Coetzee, Cathryn A Walton, et al.
Page
of 3